Fresenius Appears to Make Progress at FTC with NxStage Merger

An attorney working with a third party told CTFN that Fresenius and NxStage have strong arguments and that the companies are making their case well tofeatured

Akorn Executives Followed Kapoor from Troubled Predecessor

In August 1981, Dr. John Kapoor, presently the largest shareholder of Akorn and former CEO and chairman of the board, led a group that acquired Lyphomed from Stone Containerfeatured

Sprint/T-Mobile Tie-Up Faces Comprehensive CFIUS Review

Sprint and T-Mobile’s proposed merger announced April 29 not only has to clear hurdles with the Department of Justice and the Federal Communications Commission, but thefeatured

CTFN First Look: Sprint/T-Mobile

With additional reporting by Sarah Cohen – Sprint and T-Mobile announced on April 29 a $59 billion merger that would combine the U.S.’s third and fourth largest wireless companies. Under terms of the all-stock transaction,featured

Cavium/Marvell CFIUS Review to Focus on China

The pending Cavium/Marvell Technologies merger raises questions about how the present Committee on Foreign Investment in the United States will handle pending deals in the technology sector,featured

DOJ Looks for Guidance on Vertical Mergers from Time Warner/AT&T Case

A senior attorney in the antitrust division of the Department of Justice told CTFN on the sidelines of the American Bar Association’s antitrust section spring meeting that thefeatured

DOJ Staff Changes Further Suggest Monsanto/Bayer Review Nearly Complete

The U.S. Department of Justice appears close to wrapping up its review of Bayer’s $66 billion acquisition of Monsanto as evidenced by the recent shuffling of agency staff, CTFN has learned.featured

How a 3-2 Merger Got Done in The Present Antitrust Environment

On March 29, Energizer Holdings and Spectrum Brands announced that the Federal Trade Commission allowed expiration of the waiting period under the Hart-Scott-Rodino Antitrustfeatured

NxStage/Fresenius FTC Review Could be Helped by Recent CVS Announcement

On April 4, CVS Health announced a new initiative focused on chronic kidney disease with a planned introduction of “a truly innovative new home hemodialysis technology.” Experts featured

CTFN First Look: Humana-Walmart

Media reports suggest Walmart is in preliminary talks to buy or expand its relationship with insurer Humana. The deal would be Walmart’s largest to date, topping its $10.8 billionfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.